Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Omega Diagnostics ( (GB:CNSL) ) has shared an announcement.
Cambridge Nutritional Sciences reported preliminary figures for the year to 31 March 2026 showing revenue expected at £7.0m, down from £8.3m, as orders from the Middle East and Asia were reduced or delayed amid geopolitical disruption rather than partner losses. Despite the top-line decline, underlying revenue grew about 11% when excluding affected regions, supported notably by the U.K. and Indian markets.
The company lifted its gross margin to 67.8% from 65.3% through efficiency and cost-control measures but expects to swing to an adjusted EBITDA loss of £0.4m versus a £0.4m profit a year earlier, with net cash falling to £2.6m from £4.9m. Management highlighted ongoing investment in its IVDR development programme and new capital equipment, positioning the business for longer-term product, cost and market advantages even as it remains cautious about continued global uncertainties.
Spark’s Take on CNSL Stock
According to Spark, TipRanks’ AI Analyst, CNSL is a Neutral.
The overall stock score is primarily influenced by the mixed financial performance and bearish technical indicators. While the valuation suggests the stock may be undervalued, significant financial and technical challenges weigh heavily on the score. The positive sentiment from leadership’s share acquisitions provides a minor offset but is not enough to significantly alter the overall outlook.
To see Spark’s full report on CNSL stock, click here.
More about Omega Diagnostics
Cambridge Nutritional Sciences plc is a specialist medical diagnostics company listed on AIM, focused on tests that support a personalised and functional approach to health and nutrition. The group operates in markets including the U.K., India, the Middle East and Asia, targeting demand for nutrition-led healthcare and diagnostic solutions.
Average Trading Volume: 195,342
Technical Sentiment Signal: Sell
Current Market Cap: £4.64M
Find detailed analytics on CNSL stock on TipRanks’ Stock Analysis page.